RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Vivek R. Nerurkar to Mucocutaneous Lymph Node Syndrome

Back to Details
This is a "connection" page, showing publications Vivek R. Nerurkar has written about Mucocutaneous Lymph Node Syndrome.
Vivek R. Nerurkar
Connection Strength
0.374
Mucocutaneous Lymph Node Syndrome
  1. Chua PK, Melish ME, Yu Q, Yanagihara R, Yamamoto KS, Nerurkar VR. Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease. Clin Diagn Lab Immunol. 2003 Mar; 10(2):308-14.
    View in: PubMed
    Score: 0.220
  2. Bratincsak A, Limm-Chan BN, Nerurkar VR, Ching LL, Reddy VD, Lim E, Shohet RV, Melish ME. Study design and rationale to assess Doxycycline Efficacy in preventing coronary Artery Lesions in children with Kawasaki disease (DEAL trial) - A phase II clinical trial. Contemp Clin Trials. 2018 02; 65:33-38.
    View in: PubMed
    Score: 0.153
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support